| |
| Issue |
Title |
| |
| No 1 (2020) |
The relationship between the content of the potential psychopharmacological agent cyclo-L-prolylglycine in the brain of experimental animals and its antihypoxic effect |
Abstract
PDF (Rus)
|
|
V. P. Zherdev, S. S. Boyko, K. N. Kolyasnikova |
| |
| No 4 (2019) |
HPLC-MS method development and validation for simultaneous quantitation of GZK-111 and CPG compounds in rat plasma |
Abstract
PDF (Rus)
|
|
A. L. Podolko, P. O. Bochkov, G. B. Kolyvanov, A. A. Litvin, O. G. Gribakina, R. V. Shevchenko, V. P. Zherdev |
| |
| No 3 (2019) |
Comparative pharmacokinetics and pharmacodinamics of noopept, its activity metabolite cycloprolylglycine and piracetam |
Abstract
PDF (Rus)
|
|
Svetlana Boyko, Ksenia Kolyasnikova, Vladimir Zherdev |
| |
| No 1 (2016) |
Comparative study of the pharmacokinetics and biodistribution of various topical formulations of carbazole derivative CBL0100 in guinea pigs |
Abstract
PDF (Rus)
|
|
N. V. Eremina, V. I. Kazey, O. Y. Kravtsova, E. I. Skrabelinskaya, A. V. Purmal, A. D. Durnev |
| |
| No 1 (2019) |
The study of the permeability of the blood-brain barrier for new neurotropic peptide drugs |
Abstract
PDF (Rus)
|
|
V. P. Zherdev, S. S. Boyko, R. V. Shevchenko |
| |
| No 1 (2019) |
Pharmacokinetics of dipeptide mimetic BDNF GSB-106 in rats |
Abstract
PDF (Rus)
|
|
V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, O. G. Gribakina, R. V. Shevchenko, A. V. Tarasyuk, T. A. Gudasheva |
| |
| No 2 (2019) |
Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms |
Abstract
PDF (Rus)
|
|
O. G. Gribakina, R. V. Shevchenko, P. O. Bochkov, A. A. Novitskiy, A. A. Litvin, G. B. Kolyvanov, V. P. Zherdev |
| |
| No 2 (2019) |
Development and validation of the quantification of GIZH-298, possessing in the rat blood plasma by HPLC-UF |
Abstract
PDF (Rus)
|
|
O. G. Gribakina, R. V. Shevchenko, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, S. S. Boyko, V. P. Zherdev |
| |
| 1 - 8 of 8 Items |
|
